NCT04953234View on ClinicalTrials.gov

Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

April 26, 2021

Study Completion Date

April 26, 2021

Conditions
COVID-19
Interventions
DEVICE

NovoTTF-100L

Patients receive continuous TTFields treatment using the NovoTTF-100L device. TTFields treatment will consist of wearing four electrically insulated electrode arrays on the thorax. The treatment enables the patient to maintain regular daily routine.

Trial Locations (1)

Unknown

Hadassah Medical Center, Jerusalem

All Listed Sponsors
lead

NovoCure GmbH

INDUSTRY

NCT04953234 - Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge | Biotech Hunter | Biotech Hunter